Align Technology, Inc.
Every calculator, already run for ALGN
Open the full toolkit →You have the numbers on ALGN. Get the argument.
A written report on which of these readings actually decide the outcome for Align Technology, Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
17 analysts covering ALGNAnalyst Price Target Disagreement for Align Technology, Inc.
Wall Street's bull case implies +32% from the current price; the bear case implies -6%. A 39% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
About Align Technology, Inc.
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus;…
ALGN — frequently asked
Is ALGN a buy right now?
Wall Street's consensus rating on Align Technology, Inc. is Buy across 17 analysts, with a mean price target of $208.60 (+15% vs. the current $181.31). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is ALGN overvalued?
ALGN trades at 30.6x trailing earnings, against a DCF fair value of $107 per share. The current price implies 14% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is ALGN's next earnings date?
Align Technology, Inc. is next scheduled to report earnings around Oct 28, 2026. A full ALGN research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for Align Technology, Inc.?
Analysts covering Align Technology, Inc. (ALGN) range from a bear-case target of $170.00 to a bull-case high of $240.00, with a mean consensus target of $208.60 across 15 analysts. The spread of $70.00 (39% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare Align Technology, Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Align Technology, Inc.
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full ALGN research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Align Technology, Inc., in minutes. 3 free reports included with every account — no credit card required.